We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Blood Protein Profile Indicates Early-Onset Coronary Heart Disease

By LabMedica International staff writers
Posted on 24 Nov 2025

People with a family history of early-onset coronary heart disease often face a higher risk despite normal cholesterol or blood pressure, and current screening tools don’t fully explain why. More...

Now, a new study reveals that a distinct pattern of circulating proteins may serve as early warning markers of hereditary atherosclerosis, offering a biological explanation for this elevated risk.

In the study, researchers at Karolinska Institutet (Stockholm, Sweden) analyzed blood samples from more than 4,000 individuals without diagnosed heart disease and linked them to documented cardiovascular histories of the participants’ parents and siblings. The study identified 38 proteins, many of them involved in inflammation and lipid metabolism, that were significantly more prevalent in individuals with a family history of cardiovascular disease.

The team measured protein levels and compared them with detailed clinical imaging and registry data. They drew on the large Swedish SCAPIS population study, which includes computed tomography of coronary arteries, and matched these results with family histories from the Swedish Multigenerational Register. Among people with hereditary risk, coronary atherosclerosis was more extensive, reflected by a greater number of diseased coronary segments. Some proteins also showed stronger correlations with the severity of vessel disease, including the LDL receptor and PECAM1, both known to influence vascular function.

Researchers then applied genetic analyses to explore whether any of these proteins had a direct causal link to developing heart attacks. The findings pointed to follistatin, PCSK9, and PECAM1 as potential drivers of disease development. These results align with known biological pathways in coronary artery disease and suggest that certain proteins could mediate inherited susceptibility independent of lifestyle factors.

This work, published in the journal Circulation: Genomic and Precision Medicine, highlights a potential protein-based signature that may help explain why individuals with a family history face a higher risk even when traditional markers appear normal. It may eventually guide earlier intervention, improved risk stratification, and better understanding of the mechanisms behind hereditary and non-hereditary coronary artery disease.

“Our results suggest that there is a specific biological pattern connected to hereditary atherosclerotic disease, which may help to explain why some people are affected despite leading a healthy lifestyle,” said Associate Professor Per Svensson, last author of the study.

Related Links:
Karolinska Institutet


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
New
Portable POCT Blood Gas Analyzer
BD100
New
Automated Immunoassay Analyzer
SuperFlex™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: New research demonstrates that an electrical “fingerprint” on extracellular vesicles can be exploited to enrich cancer-associated signals (Image Credit: Shutterstock)

Electrical Fingerprint of Extracellular Vesicles Could Detect Pancreatic Cancer

Pancreatic cancer is often diagnosed only after it has spread, contributing to a five-year survival rate of 13%. Standard blood-based analyses can struggle to distinguish tumor signals from the background... Read more

Microbiology

view channel
Image: The current BDBV outbreak in the DRC underscores response challenges for rare, severe infections (Image Credit: 123RF)

Research Strengthens Bundibugyo Virus Outbreak Readiness with Faster Diagnostics

Bundibugyo virus (BDBV), a species of ebolavirus, causes severe hemorrhagic disease and can be difficult to diagnose rapidly during outbreaks. Recent regulatory changes have further complicated swift deployment... Read more

Technology

view channel
Image: The 5811 R retains the performance and versatility of its predecessor while adding a new design, a refreshed user interface, and updated sustainable cooling technology. (Photo courtesy of Eppendorf)

New Multipurpose Centrifuge Combines High Capacity with Sustainable Cooling

Laboratories often need centrifugation that accommodates multiple vessel formats while maintaining controlled temperatures to protect sensitive samples. Intuitive controls and repeatable operation can... Read more

Industry

view channel
Image: The combined offering is designed to streamline workflows and support multicolor applications used in leukemia, lymphoma, and measurable residual disease assessment in specialized clinical settings

Sysmex and Cytek Collaboration Expands Access to Advanced Clinical Flow Cytometry

Sysmex Europe SE (Hamburg, Germany) and Cytek Biosciences (Fremont, CA, USA) are partnering across more than a dozen European countries to expand access to advanced clinical flow cytometry.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.